Literature DB >> 17590453

Characterization of the activity of human MAP kinase-interacting kinase Mnk1b.

Ana O'Loghlen1, Víctor M González, Teresa Jurado, Matilde Salinas, M Elena Martín.   

Abstract

Human mitogen-activated protein (MAP) kinase interacting kinase 1b (Mnk1b) is a splice variant of human Mnk1a, which has been identified in our laboratory [A. O'Loghlen, V.M. Gonzalez, D. Pineiro, M.I. Perez-Morgado, M. Salinas, M.E. Martin, Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1, Exp. Cell Res. 299 (2004) 343-355]. Mnk1b has much higher basal eIF4E kinase activity than Mnk1a. Because Mnk1b presents different features in its C-terminus with respect to Mnk1a, we have studied in this paper the potential role of these structural differences in determining the higher basal eIF4E kinase activity as well as the subcellular localization of Mnk1b. In this paper, we demonstrate that phosphorylation of the Thr209 and Thr214 in the activation loop of Mnk1b is necessary for its activation. However, the different kinase activity between Mnk1a and Mnk1b is independent of the phosphorylation status of the activation loop residues. By deletion of the C-terminal tail in Mnk1a, we confirmed that the absence of this sequence is not responsible for the higher eIF4E kinase activity present in Mnk1b. Moreover, our findings support a crucial role of the 12 amino acids, particularly the Ala344, in the C-terminal specific region of Mnk1b (Mnk1bSR), on the kinase activity of the protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590453     DOI: 10.1016/j.bbamcr.2007.05.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Phosphorylation and Signal Transduction Pathways in Translational Control.

Authors:  Christopher G Proud
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

Review 2.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

3.  Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses.

Authors:  Sonali Joshi; Leonidas C Platanias
Journal:  Biomol Concepts       Date:  2012-04

Review 4.  Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.

Authors:  Ewa M Kosciuczuk; Diana Saleiro; Leonidas C Platanias
Journal:  Cytokine       Date:  2016-04-16       Impact factor: 3.861

Review 5.  Targeting Mnks for cancer therapy.

Authors:  Jinqiang Hou; Frankie Lam; Christopher Proud; Shudong Wang
Journal:  Oncotarget       Date:  2012-02

6.  Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

Authors:  Elisabeth Bou-Petit; Stefan Hümmer; Helena Alarcon; Konstantin Slobodnyuk; Marta Cano-Galietero; Pedro Fuentes; Pedro J Guijarro; María José Muñoz; Leticia Suarez-Cabrera; Anna Santamaria; Roger Estrada-Tejedor; José I Borrell; Santiago Ramón Y Cajal
Journal:  J Med Chem       Date:  2022-04-13       Impact factor: 8.039

7.  Molecular and Functional Characterization of ssDNA Aptamers that Specifically Bind Leishmania infantum PABP.

Authors:  Natalia Guerra-Pérez; Edurne Ramos; Marta García-Hernández; Celia Pinto; Manuel Soto; M Elena Martín; Víctor M González
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

Review 8.  Redox modulation of muscle mass and function.

Authors:  M C Gomez-Cabrera; C Arc-Chagnaud; A Salvador-Pascual; T Brioche; A Chopard; G Olaso-Gonzalez; J Viña
Journal:  Redox Biol       Date:  2020-04-18       Impact factor: 11.799

9.  Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells.

Authors:  Eva M García-Recio; Celia Pinto-Díez; M Isabel Pérez-Morgado; Marta García-Hernández; Gerónimo Fernández; M Elena Martín; Víctor M González
Journal:  Mol Ther Nucleic Acids       Date:  2016-01-05       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.